Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 9/2001

01-11-2001

Body size and ovarian cancer: case–control study and systematic review (Australia)

Authors: David M. Purdie, Christopher J. Bain, Penelope M. Webb, David C. Whiteman, Sandi Pirozzo, Adèle C. Green

Published in: Cancer Causes & Control | Issue 9/2001

Login to get access
Metadata
Title
Body size and ovarian cancer: case–control study and systematic review (Australia)
Authors
David M. Purdie
Christopher J. Bain
Penelope M. Webb
David C. Whiteman
Sandi Pirozzo
Adèle C. Green
Publication date
01-11-2001
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 9/2001
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1012267619561

Other articles of this Issue 9/2001

Cancer Causes & Control 9/2001 Go to the issue

OriginalPaper

Pooled exposure–response analyses and risk assessment for lung cancer in 10 cohorts of silica-exposed workers: an IARC multicentre study

OriginalPaper

Passive smoking at home and cancer risk: a population-based prospective study in Japanese nonsmoking women

Editorial Commentary

Lung cancer: another good reason to control silica

OriginalPaper

Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States)

OriginalPaper

Recent trends and future projections of lymphoid neoplasms – a Bayesian age–period–cohort analysis

OriginalPaper

Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in China
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits